Turnstone Biologics Raises $41.4 Million Series B Financing
Turnstone Biologics Inc. announced today the completion of a $41.4 million series B financing led by new investor OrbiMed with participation from new investor F-Prime Capital Partners and existing investors FACIT and Versant Ventures, which led Turnstone’s series A financing. […]